features: Chronic Lymphocytic Leukemia

Bruton’s tyrosine kinase (BTK) plays an essential role in the B-cell antigen receptor signaling pathway and is required for the…

A session with experts John Gribben, Alessandra Tedeschi, Meghan Thompson & Matthew Davids, who discuss the latest chronic lymphocytic leukemia…

  VJHemOnc brings you roundtable discussions with leading hematological experts in myeloma, AML, CLL, ALL, lymphoma, MDS and MPNs.

VJHemOnc is proud to present the SOHO Italy 2020 Virtual Meeting, which took place on the 22nd-24th of September 2020.

VJHemOnc was official Media Partner for the ERIC 2020 Virtual Meeting, New Frontiers in CLL Research, which took place on 1-3…

The U.S. Food and Drug Administration (FDA) has approved the first and only assay – clonoSEQ®, to screen and assess…

A five-part session with experts John Gribben, Barbara Eichhorst, Susan O’Brien and Matthew Davids who debate the key updates in…

VJHemOnc are excited to present late-breaking abstracts and key trial updates announced at this year’s virtual EHA meeting!

Following positive results gleaned from the E1912 trial (NCT02048813), the U.S. Food and Drug Administration (FDA) has expanded the indication…

Chimeric antigen receptor T-cell (CAR-T) therapies have proven particularly successful in hematological malignancies. However, CAR T-cells still underperform when used…

Discover the next-generation of MRD assessment. Gain insights into the science of molecular testing and its potential

Watch webcast presentations from the ERIC 2018 International Meeting now!